EUVIMEDEUVIMED entdecken
Crossref

Bruton's tyrosine kinase inhibition suppresses pathological retinal angiogenesis

Siyue Chen iD, Yuming Liu, Yutian Zhang, Xu Guo, Tinghui Bai, Kai He, Yanfang Zhu, Yi Lei, Mei Du, Xiaohong Wang, Qiang Liu, Hua Yan iD

British Journal of Pharmacology · 2025

DOI: 10.1111/bph.17344 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, 2025. Verfasst von Siyue Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Tianjin Medical University General Hospital, Ministry of Education International Joint Laboratory of Ocular Diseases, Ti…. Hauptthemen laut MEDLINE: Agammaglobulinaemia Tyrosine Kinase, Retinal Neovascularization, Protein Kinase Inhibitors, Angiogenesis Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 117 Literaturangaben. Gefördert von: Natural Science Foundation of Tianjin Municipality, National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Pathological retinal angiogenesis is a typical manifestation of vision‐threatening ocular diseases. Many patients exhibit poor response or resistance to anti‐vascular endothelial growth factor (VEGF) agents. Bruton's tyrosine kinase (BTK) controls the proliferation and function of immune cells. Therefore, we examined the anti‐inflammatory and anti‐angiogenic effects of BTK inhibition on retinal angiogenesis. Experimental Approach Retinal neovascularisation and vascular leakage in oxygen‐induced retinopathy in C57/BL6J mice were assessed by whole‐mount retinal immunofluorescence. PLX5622 was used to deplete microglia and Rag1 ‐knockout mice were used to test the contribution of lymphocytes to the effects of BTK inhibition. The cytokines, activation markers, inflammatory and immune‐regulatory activities of retinal microglia/macrophages were detected using qRT‐PCR and immunofluorescence. NLRP3 was detected by western blotting, and the effects of BTK inhibition on the co‐culture of microglia and human retinal microvascular endothelial cells (HRMECs) were examined. Key Results BTK inhibition suppressed pathological angiogenesis and vascular leakage, and significantly reduced retinal inflammation, which involved microglia/macrophages but not lymphocytes. BTK inhibition increased anti‐inflammatory factors and reduced pro‐inflammatory cytokines that resulted from NLRP3 inflammasome activation. BTK inhibition suppressed the inflammatory activity of microglia/macrophages, and acted synergistically with anti‐VEGF without retinal toxicity. Moreover, the supernatant of microglia incubated with BTK‐inhibitor reduced the proliferation, tube formation and sprouting of HRMECs. Conclusion and Implications BTK inhibition suppressed retinal neovascularisation and vascular leakage by modulating the inflammatory activity of microglia and macrophages. Our study suggests BTK inhibition as a novel and promising approach for alleviating pathological retinal angiogenesis. LINKED ARTICLES This article is part of a themed issue Drugs and Drug Targets in Metabolic and Chronic Inflammatory Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v182.20/issuetoc

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Agammaglobulinaemia Tyrosine KinaseRetinal NeovascularizationProtein Kinase InhibitorsAngiogenesis InhibitorsAnimalsMice, Inbred C57BLMiceHumansMicrogliaMice, KnockoutMaleRetinaAngiogenesis

Stichwörter der Autor:innen

Bruton's tyrosine kinaseanti‐angiogenic drugspathological angiogenesisretinal microglia/macrophages

Substanzen

Agammaglobulinaemia Tyrosine KinaseProtein Kinase InhibitorsBtk protein, mouseAngiogenesis Inhibitors

Autor:innen und Institutionen

  • Department of Ophthalmology, Tianjin Medical University General Hospital, Ministry of Education International Joint Laboratory of Ocular Diseases, Tianjin Key Laboratory of Ocular Trauma, Tianjin Institute of Eye Health…
  • Department of Pharmacology, Tianjin Key Laboratory of Inflammation Biology, the Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, School of Basic Medical Sciences, Tianjin Medic…
  • Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China.

ORCID-Profile: Siyue Chen, Hua Yan

Förderung

  • Natural Science Foundation of Tianjin Municipality
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Chen, S., Liu, Y., Zhang, Y., Guo, X., Bai, T., He, K., Zhu, Y., Lei, Y., Du, M., Wang, X., Liu, Q., & Yan, H. (2025). Bruton's tyrosine kinase inhibition suppresses pathological retinal angiogenesis. British Journal of Pharmacology. https://doi.org/10.1111/bph.17344

Vancouver

Chen S, Liu Y, Zhang Y, Guo X, Bai T, He K, et al. Bruton's tyrosine kinase inhibition suppresses pathological retinal angiogenesis. British Journal of Pharmacology. 2025. doi:10.1111/bph.17344

BibTeX
@article{Chen2025,
  author = {Chen, Siyue and Liu, Yuming and Zhang, Yutian and Guo, Xu and Bai, Tinghui and He, Kai and Zhu, Yanfang and Lei, Yi and Du, Mei and Wang, Xiaohong and Liu, Qiang and Yan, Hua},
  title = {Bruton's tyrosine kinase inhibition suppresses pathological retinal angiogenesis},
  journal = {British Journal of Pharmacology},
  year = {2025},
  doi = {10.1111/bph.17344}
}
Kostenlos starten →